Infosys shares declined on August 17, closing at $11.62 amid broader volatility, with the stock remaining undervalued according to GuruFocus, though insider selling raises caution for investors.
Infosys shares fell 3.9% on August 17, closing at $11.62 and extending a volatile year in which the stock has traded between $10.30 and $30.00, according to GuruFocus. The research site said the price now sits well below its GF Value estimate of $19.02, implying the shares are about 38.9% below its estimate of fair value.
Even so, the valuation case is being tempered by signs that investors are watching the company more cautiously. GuruFocus assigned Infosys a GF Score of 86 out of 100, pointing to strong profitability, financial strength and growth, but a weak momentum reading suggests the market has not yet embraced that strength. The site also noted that the stock’s price-to-earnings ratio of 14.3 times is far below its five-year median of 25.7 times, which reinforces the view that the shares are inexpensive relative to history.
The latest note follows a series of similar assessments in recent weeks. On July 8, GuruFocus said the stock was down 3% to $10.93 and estimated 43.5% upside based on a GF Value of $19.35. On July 24 and July 27, it again described the shares as undervalued even as the stock moved higher on some sessions, with GF Scores holding at 86 and insider selling still standing out as a concern. On July 14, the site said the stock had fallen 3.9% to $11.05 and cited a GF Value of $19.22.
That insider activity remains the clearest warning sign in the analysis. GuruFocus said insiders have sold $119.4 million worth of shares over the past 12 months, with no reported purchases. While the company’s fundamentals still appear solid, that pattern can signal caution from people closest to the business. For investors, the message is mixed: the stock looks cheap on paper, but sentiment, momentum and insider behaviour argue for care rather than conviction.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
